Wednesday, November 03, 2021 12:23:11 AM
Welcome New Investors (see a note to all our new CYDY investors near the end of this post)
C-20 Check out the chart! - things are changing RADICALLY.
https://otcshortreport.com/company/CYDY?index=mdmn&action=view#.U6o6Ktq9KSO
While the "short" volume (other than the last two Fridays) has been at least a million per day,
the regular volume for the last few days is getting notably larger. As the price descends - folks are buying in at bargain prices!
(May be time for our Market Maven - the venerable Black-Ops, to fill the newbies in on "why he suggests NOT using 'stop loss!' He's great at explaining why it is a VERY BAD IDEA.")
Folks aren't running from - their running to >>>>> CYDY.
I can only guess they're seeing through the "smoke", getting glimpses of the "golden fleece" and
"putting their money down!!"
so....
Welcome New Investors - to the most amazing drug in town!!
Do your DD and then, "hang on for the ride of your life!"
The CytoDyn website (google CytoDyn.com) offers lots of information on Leronlimab - CytoDyn's only drug - but 'what a drug' it is! As you read, you'll begin to comprehend why control of Leronlimab is so hotly contested - stuff appears to be amazing - but explore for yourself!
All >> In-My-Opinion (as always) my posts are for your entertainment and are my opinion. THIS IS NOT TO BE CONSTRUED AS INVESTMENT ADVICE.
C-20 Check out the chart! - things are changing RADICALLY.
https://otcshortreport.com/company/CYDY?index=mdmn&action=view#.U6o6Ktq9KSO
While the "short" volume (other than the last two Fridays) has been at least a million per day,
the regular volume for the last few days is getting notably larger. As the price descends - folks are buying in at bargain prices!
(May be time for our Market Maven - the venerable Black-Ops, to fill the newbies in on "why he suggests NOT using 'stop loss!' He's great at explaining why it is a VERY BAD IDEA.")
Folks aren't running from - their running to >>>>> CYDY.
I can only guess they're seeing through the "smoke", getting glimpses of the "golden fleece" and
"putting their money down!!"
so....
Welcome New Investors - to the most amazing drug in town!!
Do your DD and then, "hang on for the ride of your life!"
The CytoDyn website (google CytoDyn.com) offers lots of information on Leronlimab - CytoDyn's only drug - but 'what a drug' it is! As you read, you'll begin to comprehend why control of Leronlimab is so hotly contested - stuff appears to be amazing - but explore for yourself!
All >> In-My-Opinion (as always) my posts are for your entertainment and are my opinion. THIS IS NOT TO BE CONSTRUED AS INVESTMENT ADVICE.
Recent CYDY News
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
